Pain has always been in the eye of the beholder. Doctors evaluating patients, as well as scientists studying pain, have had to rely on subjective descriptions, making pain notoriously difficult to measure and track. A new study from Stanford University takes a first step toward an objective measure for pain.
Researchers found that by pairing functional MRI (fMRI) with a machine-learning algorithm, they could detect specific patterns of brain activity that predicted whether someone was experiencing pain or not. The researchers hope to expand the tool to find brain signatures representing different levels and types of pain, a technology that might one day be useful in clinical practice, drug trials, and pain research.
Scientists have already used fMRI to study the underlying brain structures and patterns of activity involved in pain. But Sean Mackey, a pain researcher and anesthesiologist at Stanford School of Medicine, says that “what we have never done to date is show that you can use that pattern of information to determine whether someone is in pain or not.”
To do that, his team imaged the brain activity of eight people whose skin had been exposed to a heat probe that was modulated to feel either painful or not painful. They used a support vector machine—an algorithm capable of learning and adapting—to analyze the data for patterns of activity common among the subjects.
Researchers have paired brain imaging with pattern-recognition software for more than a decade as a way of decoding brain states or activities—to determine if a subject is performing a particular task or seeing a particular object, for instance.
When the researchers gave the pair of painful and nonpainful heat sensations to 16 new subjects, they found they could separate the two conditions with more than 81 percent accuracy. The research was published online today in PLoS ONE.
Mackey emphasizes that the findings are preliminary. Real-life pain is complex, and this experiment was performed with a small group of subjects in controlled laboratory conditions. But he says the study offers initial evidence that pain, often thought of as entirely subjective, has features that can be measured objectively. “There are some commonalities in these neural signatures from one person to another,” he says.
David Borsook, a pain researcher at McLean Hospital and Harvard Medical School, says that finding an objective measure of pain could radically change how patients are treated. Many scientists have been looking for biomarkers of pain, and Borsook, who was not involved in the study, believes the concept of finding patterns in brain-imaging data “will turn out to be a very robust and useful approach.”
To be useful, such a technique would need to be able to differentiate various types of pain. The Stanford team is evaluating whether the technique can measure chronic pain, rather than a single painful stimulus.
Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.